Oral drug for ulcerative colitis safety study
Part of Digestive system clinical trials.
This study tests an investigational oral drug for ulcerative colitis. It is an early-stage trial to check safety and how the drug is processed by the body in both healthy volunteers and patients with active ulcerative colitis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 and older (healthy volunteers: 18 to 55)
- For healthy volunteers: must be generally healthy, with a body mass index between 18.0 and 32.0
- For patients: must have a diagnosis of ulcerative colitis for at least 3 months
- No prior major colon surgery for ulcerative colitis
- No recent changes to certain UC medications (like steroids, biologics, or immunosuppressants)
- Willing to abstain from alcohol and recreational drugs for a long period, and avoid pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This study tests a new medication (called 627) for people with moderate to severe ulcerative colitis who haven't responded well to or couldn't tolerate other treatments. The goal is to see if it can safely reduce inflammation and improve symptoms.
This trial tests an experimental drug called ENC1018 for people with moderate-to-severe ulcerative colitis who haven't responded well to standard treatments. It aims to see if the drug is safe and works well.
This trial tests an oral tablet called AC-101 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation in the colon and improve symptoms.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This trial tests an investigational drug called LIV001 in people with mild-to-moderate ulcerative colitis. It aims to see if the medicine can help calm inflammation in the colon and improve symptoms.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.